Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Édouard Brissaud: distinguished neurologist and Charcot's pupil.

Marques PT, Germiniani FMB, Camargo CHF, Munhoz RP, Teive HAG.

Arq Neuropsiquiatr. 2018 Jul;76(7):490-493. doi: 10.1590/0004-282X20180063.

2.

Yawning in neurology: a review.

Teive HAG, Munhoz RP, Camargo CHF, Walusinski O.

Arq Neuropsiquiatr. 2018 Jul;76(7):473-480. doi: 10.1590/0004-282X20180057. Review.

3.

Decisions about deep brain stimulation therapy in Parkinson's disease.

Brandão P, Grippe TC, Modesto LC, Ferreira AGF, Silva FMD, Pereira FF, Lobo ME, Allam N, Freitas TDS, Munhoz RP.

Arq Neuropsiquiatr. 2018 Jun;76(6):411-420. doi: 10.1590/0004-282X20180048. Review.

4.

Tardive Akathisia with Asymmetric and Upper-body Presentation: Report of Two Cases and Literature Review.

Shahidi G, Rohani M, Munhoz RP, Akhoundi FH.

Tremor Other Hyperkinet Mov (N Y). 2018 May 29;8:563. doi: 10.7916/D8224B00. eCollection 2018.

5.

Olfactory Function in SCA10.

Moscovich M, Munhoz RP, Moro A, Raskin S, McFarland K, Ashizawa T, Teive HAG, Silveira-Moriyama L.

Cerebellum. 2018 Jun 19. doi: 10.1007/s12311-018-0954-1. [Epub ahead of print]

PMID:
29922950
6.

Botulinum toxin for hereditary spastic paraplegia: effects on motor and non-motor manifestations.

Servelhere KR, Faber I, Martinez A, Nickel R, Moro A, Germiniani FMB, Moscovich M, Blume TR, Munhoz RP, Teive HAG, França MC Jr.

Arq Neuropsiquiatr. 2018 Mar;76(3):183-188. doi: 10.1590/0004-282x20180013.

7.

Body composition in Spinocerebellar ataxia type 3 and 10 patients: Comparative study with control group.

Leite CMBA, Schieferdecker MEM, Frehner C, Munhoz RP, Ashizawa T, Teive HAG.

Nutr Neurosci. 2018 May 7:1-6. doi: 10.1080/1028415X.2018.1469282. [Epub ahead of print]

PMID:
29734917
8.

Sleep disorders in spinocerebellar ataxia type 10.

London E, Camargo CHF, Zanatta A, Crippa AC, Raskin S, Munhoz RP, Ashizawa T, Teive HAG.

J Sleep Res. 2018 Oct;27(5):e12688. doi: 10.1111/jsr.12688. Epub 2018 Apr 6.

PMID:
29624773
9.

A 21-Year Retrospective Study of the Toronto Western Hospital Deep Brain Stimulation Cohort.

Cubo E, Rajalingam R, Fasano A, Munhoz RP, Lang AE, Calvo S, Marras C.

Mov Disord. 2018 May;33(5):850-852. doi: 10.1002/mds.27359. Epub 2018 Mar 23. No abstract available.

PMID:
29570864
10.

Medical Management of Movement Disorders.

Picillo M, Munhoz RP.

Prog Neurol Surg. 2018;33:41-49. doi: 10.1159/000480747. Epub 2018 Jan 12. Review.

PMID:
29332072
11.

Predictors of deep brain stimulation outcome in tremor patients.

Sandoe C, Krishna V, Basha D, Sammartino F, Tatsch J, Picillo M, di Biase L, Poon YY, Hamani C, Reddy D, Munhoz RP, Lozano AM, Hutchison WD, Fasano A.

Brain Stimul. 2018 May - Jun;11(3):592-599. doi: 10.1016/j.brs.2017.12.014. Epub 2018 Jan 2.

PMID:
29330020
12.

More than ataxia - Movement disorders in ataxia-telangiectasia.

Teive HAG, Camargo CHF, Munhoz RP.

Parkinsonism Relat Disord. 2018 Jan;46:3-8. doi: 10.1016/j.parkreldis.2017.12.009. Epub 2017 Dec 12. Review.

PMID:
29249681
13.

Different Cerebellar Ataxia Phenotypes Associated with Mutations of the PNPLA6 Gene in Brazilian Patients with Recessive Ataxias.

Teive HAG, Camargo CHF, Sato MT, Shiokawa N, Boguszewski CL, Raskin S, Buck C, Seminara SB, Munhoz RP.

Cerebellum. 2018 Jun;17(3):380-385. doi: 10.1007/s12311-017-0909-y.

14.

Tele-health for patients with deep brain stimulation: The experience of the Ontario Telemedicine Network.

Jitkritsadakul O, Rajalingam R, Toenjes C, Munhoz RP, Fasano A.

Mov Disord. 2018 Mar;33(3):491-492. doi: 10.1002/mds.27230. Epub 2017 Nov 9. No abstract available.

PMID:
29119600
15.

When shaking during standing points to hereditary spastic paraplegias.

Picillo M, Erro R, Munhoz RP, Fasano A.

Parkinsonism Relat Disord. 2018 Jan;46:92-94. doi: 10.1016/j.parkreldis.2017.10.017. Epub 2017 Oct 26. No abstract available.

PMID:
29111427
16.

Caffeine as symptomatic treatment for Parkinson disease (Café-PD): A randomized trial.

Postuma RB, Anang J, Pelletier A, Joseph L, Moscovich M, Grimes D, Furtado S, Munhoz RP, Appel-Cresswell S, Moro A, Borys A, Hobson D, Lang AE.

Neurology. 2017 Oct 24;89(17):1795-1803. doi: 10.1212/WNL.0000000000004568. Epub 2017 Sep 27.

PMID:
28954882
17.

Cognitive dysfunction in corticobasal degeneration.

Oliveira LM, Barcellos I, Teive HAG, Munhoz RP.

Arq Neuropsiquiatr. 2017 Aug;75(8):570-579. doi: 10.1590/0004-282X20170077. Review.

18.

Wilson's disease presenting as central pontine myelinolysis.

Safdarian M, Munhoz RP, Aghaei M, Rohani M.

Neurol Sci. 2017 Dec;38(12):2223-2225. doi: 10.1007/s10072-017-3064-9. Epub 2017 Aug 7. No abstract available.

PMID:
28785820
19.

Anatomic Targeting of the Optimal Location for Thalamic Deep Brain Stimulation in Patients with Essential Tremor.

King NKK, Krishna V, Sammartino F, Bari A, Reddy GD, Hodaie M, Kalia SK, Fasano A, Munhoz RP, Lozano AM, Hamani C.

World Neurosurg. 2017 Nov;107:168-174. doi: 10.1016/j.wneu.2017.07.136. Epub 2017 Jul 31.

PMID:
28774764
20.

MRI-guided focused ultrasound thalamotomy in non-ET tremor syndromes.

Fasano A, Llinas M, Munhoz RP, Hlasny E, Kucharczyk W, Lozano AM.

Neurology. 2017 Aug 22;89(8):771-775. doi: 10.1212/WNL.0000000000004268. Epub 2017 Jul 26.

PMID:
28747452
21.

Abnormal movements induced by methanol toxicity.

Rohani M, Munhoz RP, Haeri G.

Postgrad Med J. 2017 Dec;93(1106):1. doi: 10.1136/postgradmedj-2017-134947. Epub 2017 Jun 30. No abstract available.

PMID:
28667166
22.

Deep brain stimulation for Parkinson's disease: meta-analysis of results of randomized trials at varying lengths of follow-up.

Mansouri A, Taslimi S, Badhiwala JH, Witiw CD, Nassiri F, Odekerken VJJ, De Bie RMA, Kalia SK, Hodaie M, Munhoz RP, Fasano A, Lozano AM.

J Neurosurg. 2018 Apr;128(4):1199-1213. doi: 10.3171/2016.11.JNS16715. Epub 2017 Jun 30.

PMID:
28665252
23.

Charcot's irony and sarcasm.

Teive HAG, Germiniani FMB, Munhoz RP.

Arq Neuropsiquiatr. 2017 Jun;75(6):402-404. doi: 10.1590/0004-282X20170062.

24.

Charcot's famous secretaries.

Teive HAG, Germiniani FMB, Munhoz RP, Walusinski O.

Arq Neuropsiquiatr. 2017 May;75(5):320-323. doi: 10.1590/0004-282X20170034.

25.

Nonmotor Symptoms in Patients with Spinocerebellar Ataxia Type 10.

Moro A, Munhoz RP, Moscovich M, Arruda WO, Raskin S, Silveira-Moriyama L, Ashizawa T, Teive HAG.

Cerebellum. 2017 Dec;16(5-6):938-944. doi: 10.1007/s12311-017-0869-2.

PMID:
28589261
26.

Death certificate data and causes of death in patients with parkinsonism.

Moscovich M, Boschetti G, Moro A, Teive HAG, Hassan A, Munhoz RP.

Parkinsonism Relat Disord. 2017 Aug;41:99-103. doi: 10.1016/j.parkreldis.2017.05.022. Epub 2017 May 26.

PMID:
28572021
27.

Charcot and vascular Parkinsonism.

Teive HA, Germiniani FM, Munhoz RP.

Arq Neuropsiquiatr. 2017 Mar;75(3):195-196. doi: 10.1590/0004-282X20170007.

28.

Parkinson's disease - 200 years: the outstanding contribution of "Old Hubert".

Teive HA, Munhoz RP, Lees AJ.

Arq Neuropsiquiatr. 2017 Mar;75(3):192-194. doi: 10.1590/0004-282X20170006.

29.

Treatment of hemifacial spasm with botulinum toxin type a: effective, long lasting and well tolerated.

Batisti JP, Kleinfelder AD, Galli NB, Moro A, Munhoz RP, Teive HA.

Arq Neuropsiquiatr. 2017 Feb;75(2):87-91. doi: 10.1590/0004-282X20160191.

30.

SCA 35 presenting as isolated treatment-resistant dystonic hand tremor.

Fasano A, Hodaie M, Munhoz RP, Rohani M.

Parkinsonism Relat Disord. 2017 Apr;37:118-119. doi: 10.1016/j.parkreldis.2017.01.014. Epub 2017 Feb 10. No abstract available.

PMID:
28214262
31.

The new era and paradigms for patient consent.

Munhoz RP.

Arq Neuropsiquiatr. 2017 Jan;75(1):1-2. doi: 10.1590/0004-282X20160199. No abstract available.

32.

Zolpidem in movement disorders after cardiac arrest.

Arruda WO, Silva MS, Bertholdo DB, Munhoz RP, Teive HA.

Parkinsonism Relat Disord. 2017 Apr;37:114-115. doi: 10.1016/j.parkreldis.2017.01.007. Epub 2017 Jan 11. No abstract available.

PMID:
28094104
33.

Fatal Status Dystonicus in Tardive Dystonia Due to Depletion of Deep Brain Stimulation's Pulse Generator.

Rohani M, Munhoz RP, Shahidi G, Parvaresh M, Miri S.

Brain Stimul. 2017 Jan - Feb;10(1):160-161. doi: 10.1016/j.brs.2016.10.006. Epub 2016 Nov 22. No abstract available.

PMID:
28017319
34.

Charcot, Mitchell and Lees: neurology free thinkers and their experiences of psychoactive drugs.

Teive HA, Germiniani FM, Kowacs PA, Munhoz RP.

Arq Neuropsiquiatr. 2016 Dec;74(12):1035-1038. doi: 10.1590/0004-282X20160160.

35.

Not all drug-induced parkinsonism are the same: the effect of drug class on motor phenotype.

Munhoz RP, Bertucci Filho D, Teive HA.

Neurol Sci. 2017 Feb;38(2):319-324. doi: 10.1007/s10072-016-2771-y. Epub 2016 Nov 16.

PMID:
27853909
36.

Classification and Characteristics of Pain Associated with Parkinson's Disease.

Young Blood MR, Ferro MM, Munhoz RP, Teive HA, Camargo CH.

Parkinsons Dis. 2016;2016:6067132. Epub 2016 Oct 5. Review.

37.

Itajaí, Santa Catarina - Azorean ancestry and spinocerebellar ataxia type 3.

Teive HA, Moro A, Arruda WO, Raskin S, Teive GM, Dalabrida N, Munhoz RP.

Arq Neuropsiquiatr. 2016 Oct;74(10):858-860. doi: 10.1590/0004-282X20160125. Review.

38.

Unusual motor and non-motor symptoms and signs in the early stage of Parkinson's disease.

Teive HA, Bertucci DC Filho, Munhoz RP.

Arq Neuropsiquiatr. 2016 Oct;74(10):781-784. doi: 10.1590/0004-282X20160126.

39.

Medical Management of Parkinson's Disease after Initiation of Deep Brain Stimulation.

Fasano A, Appel-Cresswell S, Jog M, Zurowkski M, Duff-Canning S, Cohn M, Picillo M, Honey CR, Panisset M, Munhoz RP.

Can J Neurol Sci. 2016 Sep;43(5):626-34. doi: 10.1017/cjn.2016.274. Review.

PMID:
27670207
40.

Deep brain stimulation for the treatment of hyperkinetic movement disorders.

di Biase L, Munhoz RP.

Expert Rev Neurother. 2016 Sep;16(9):1067-78. doi: 10.1080/14737175.2016.1196139. Epub 2016 Jun 10. Review.

PMID:
27254274
41.

Low-frequency Subthalamic Stimulation in Parkinson's Disease: Long-term Outcome and Predictors.

Zibetti M, Moro E, Krishna V, Sammartino F, Picillo M, Munhoz RP, Lozano AM, Fasano A.

Brain Stimul. 2016 Sep-Oct;9(5):774-779. doi: 10.1016/j.brs.2016.04.017. Epub 2016 Apr 28.

PMID:
27198578
42.

What's in a name? Problems, facts and controversies regarding neurological eponyms.

Teive HA, Lima PM, Germiniani FM, Munhoz RP.

Arq Neuropsiquiatr. 2016 May;74(5):423-5. doi: 10.1590/0004-282X20160040. Review.

43.

Eligibility Criteria for Deep Brain Stimulation in Parkinson's Disease, Tremor, and Dystonia.

Munhoz RP, Picillo M, Fox SH, Bruno V, Panisset M, Honey CR, Fasano A.

Can J Neurol Sci. 2016 Jul;43(4):462-71. doi: 10.1017/cjn.2016.35. Epub 2016 May 3. Review.

PMID:
27139127
44.

Increased sexual arousal in patients with movement disorders.

Teive HA, Moro A, Moscovich M, Munhoz RP.

Arq Neuropsiquiatr. 2016 Apr;74(4):303-6. doi: 10.1590/0004-282X20150217.

45.

Deep Brain Stimulation Target Selection for Parkinson's Disease.

Honey CR, Hamani C, Kalia SK, Sankar T, Picillo M, Munhoz RP, Fasano A, Panisset M.

Can J Neurol Sci. 2017 Jan;44(1):3-8. doi: 10.1017/cjn.2016.22. Epub 2016 Mar 15. Review.

PMID:
26976064
46.

Programming Deep Brain Stimulation for Tremor and Dystonia: The Toronto Western Hospital Algorithms.

Picillo M, Lozano AM, Kou N, Munhoz RP, Fasano A.

Brain Stimul. 2016 May-Jun;9(3):438-452. doi: 10.1016/j.brs.2016.02.003. Epub 2016 Feb 12. Review.

PMID:
26968805
47.

Statin-associated cerebellar ataxia. A Brazilian case series.

Teive HA, Moro A, Moscovich M, Arruda WO, Munhoz RP.

Parkinsonism Relat Disord. 2016 Apr;25:97-9. doi: 10.1016/j.parkreldis.2016.02.005. Epub 2016 Feb 2.

PMID:
26897092
48.

Nonneurological Involvement in Late-Onset Friedreich Ataxia (LOFA): Exploring the Phenotypes.

Martinez AR, Moro A, Abrahao A, Faber I, Borges CR, Rezende TJ, Martins CR Jr, Moscovich M, Munhoz RP, Segal SL, Arruda WO, Saraiva-Pereira ML, Karuta S, Pedroso JL, D'Abreu A, Jardim LB, Lopes-Cendes Í, Barsottini OG, Teive HA, França MC Jr.

Cerebellum. 2017 Feb;16(1):253-256. doi: 10.1007/s12311-015-0755-8.

PMID:
26754264
49.

Idiopathic very late-onset cerebellar ataxia: a Brazilian case series.

Teive HA, Moscovich M, Moro A, Farah M, Arruda WO, Munhoz RP.

Arq Neuropsiquiatr. 2015 Nov;73(11):903-5. doi: 10.1590/0004-282X20150139.

50.

Improving outcomes of subthalamic nucleus deep brain stimulation in Parkinson's disease.

Bari AA, Fasano A, Munhoz RP, Lozano AM.

Expert Rev Neurother. 2015 Oct;15(10):1151-60. doi: 10.1586/14737175.2015.1081815. Epub 2015 Sep 17. Review.

PMID:
26377740

Supplemental Content

Loading ...
Support Center